Medications
FDA approves IV artesunate for severe malaria
Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday.
May 28, 2020
0
0
News tagged with artesunate
Diseases, Conditions, Syndromes
Guidance lists new first-line treatment for severe malaria in the U.S.
(HealthDay)—The drug artesunate—the World Health Organization-recommended first-line treatment for severe malaria—will become the first-line treatment for severe malaria in the United States, the U.S. Centers for Disease ...
Mar 29, 2019
0
2
Diseases, Conditions, Syndromes
Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
Researchers from LSTM have looked at the efficacy of using a novel artemisinin-based combination therapy (ACT), pyronaridine-artesunate, to treat malaria in areas where resistance to other ACTs is becoming a problem. The ...
Jan 8, 2019
0
9
Oncology & Cancer
Cheap malaria drug could treat colorectal cancer effectively too, say experts
Medical experts say a common malaria drug could have a significant impact on colorectal cancer providing a cheap adjunct to current expensive chemotherapy.
Nov 18, 2014
0
0
Inflammatory disorders
Study shows effectiveness of artesunate, a common herbal-based anti-malarial drug, in controlling asthma
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore (NUS).
Aug 1, 2014
0
0
Diseases, Conditions, Syndromes
Cochrane review of dihydroartemisinin-piperaquine for treating uncomplicated malaria
'Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine' concludes a systematic review published by the Cochrane Infectious Disease Group, hosted ...
Jan 21, 2014
0
0
Medications
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Apr 11, 2013
0
0
Diseases, Conditions, Syndromes
Pyramax receives positive opinion from the EMA
Pyramax, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58. This once daily, 3-day ...
Feb 21, 2012
0
0
